Description
Manufacturer
Jiangsu Hansoh Pharmaceutical Group Co. Ltd(CHINA)
Registraction Number
MAL24106021ACZ
Content:
- Active Ingredient: Fulvestrant 250mg/5ml (50mg/ml)
- Excipients: Various inactive ingredients to stabilize the solution
Indications:
- Monotherapy: Used for the treatment of hormone receptor-positive (HR-positive) advanced breast cancer in postmenopausal women with disease progression following anti-estrogen therapy.
- Combination Therapy: May be used in combination with other therapies as per the oncologist's recommendation.
Instructions:
Dosage and Administration: Administered as a single intramuscular injection once monthly. The dose is typically 500mg (2ml) administered as two 1ml injections into the buttocks.
- Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
- Handling: Use aseptic techniques to avoid contamination. Dispose of syringes and needles safely after use.
More detail about Complete Wellness
Malaysia
